Evidence map›Paper›PMID 32035159›Full record

Observational studyThe Journal of allergy and clinical immunology2020

RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness.

Tanya Novak, Mark W Hall, Douglas R McDonald, Margaret M Newhams, Anushay J Mistry, Angela Panoskaltsis-Mortari, Peter M Mourani, Laura L Loftis, Scott L Weiss, Keiko M Tarquinio and 6 more

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in The Journal of allergy and clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Antiviral Activity of Marine BacteriumInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Association of Asthma With Treatments and Outcomes in Children With Critical Influenza.The journal of allergy and clinical immunology. In practice · 2023
    Observational
  7. Pathobiology, Severity, and Risk Stratification of Pediatric Acute Respiratory Distress Syndrome: From the Second Pediatric Acute Lung Injury Consensus Conference.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Observational
  12. [Therapeutic Effect of Artesunate on Influenza A Viral Pneumonia].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2022
    Article
  13. Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  14. Immune Function in Critically Ill Septic Children.Pathogens (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Tanya NovakBoston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass; Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass; Department of Anesthesia, Harvard Medical School, Boston.
Mark W HallNationwide Children's Hospital, Division of Critical Care Medicine, Department of Pediatrics, Columbus, Ohio.
Douglas R McDonaldBoston Children's Hospital, Division of Immunology and Harvard Medical School Department of Pediatrics, Boston, Mass.
Margaret M NewhamsBoston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass.
Anushay J MistryBoston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass.
Angela Panoskaltsis-MortariCytokine Reference Laboratory, Department of Pediatrics, University of Minnesota, Minneapolis, Minn.
Peter M MouraniSection of Critical Care Medicine, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colo.
Laura L LoftisSection of Critical Care Medicine, Department of Pediatrics, Texas Children's Hospital, Houston, Tex.
Scott L WeissDepartment of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, Pa.
Keiko M TarquinioDivision of Pediatric Critical Care Medicine, Children's Healthcare of Atlanta at Egleston, Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga.
Barry MarkovitzDepartment of Anesthesiology Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, Calif.
Mary E HartmanDepartment of Pediatrics, St Louis Children's Hospital, St Louis, Mo.
Adam SchwarzDepartment of Pediatrics, Children's Hospital of Orange County, Orange, Calif.
Wolfgang G JungerDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.
Adrienne G RandolphBoston Children's Hospital, Department of Anesthesiology, Critical Care and Pain Medicine, Boston, Mass; Department of Anesthesia, Harvard Medical School, Boston. Electronic address: adrienne.randolph@childrens.harvard.edu.
PALISI Pediatric Intensive Care Influenza (PICFLU) Network Investigators
Boston Children's Hospital · USChildren's Hospital Colorado · USChildren's Hospital of Los Angeles · USChildren's Hospital of Orange County · USChildren's Hospital of Philadelphia · USEmory University · USNationwide Children's Hospital · USSt. Louis Children's Hospital · USTexas Children's Hospital · USUniversity of Minnesota · USBeth Israel Deaconess Medical Center · US

Funding

Genetic Epidemiology of Life-Threatening Influenza in ChildrenR01AI084011 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI RANDOLPH, ADRIENNE G · 2010 to 2013
$3.1M
Metabolic and purinergic immune regulationR35GM136429 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JUNGER, WOLFGANG G · 2020 to 2024
$2.3M
Role of purinergic signaling in pediatric multi-organ failureR01HD098363 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JUNGER, WOLFGANG G · 2019 to 2023
$2.0M
Autocrine regulation of neutrophil chemotaxisR01GM116162 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JUNGER, WOLFGANG G · 2015 to 2018
$1.6M
Harvard Trauma Inflammation Training ProgramT32GM103702 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JUNGER, WOLFGANG G · 2013 to 2017
$922k
Genetic Epidemiology of Life-Threatening Influenza Infection in ChildrenR56AI084011 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI RANDOLPH, ADRIENNE G · 2009 to 2009
$712k
Genes Associated with MODS in Children with Severe Acute Respiratory InfectionsR21HD095228 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI RANDOLPH, ADRIENNE G · 2018 to 2019
$445k
NIAID NIH HHS R01 AI084011NIAID NIH HHS R56 AI084011NICHD NIH HHS R01 HD098363NICHD NIH HHS R21 HD095228NIGMS NIH HHS R01 GM116162NIGMS NIH HHS R35 GM136429NIGMS NIH HHS T32 GM103702
6 · The paper itself

Abstract

backgroundDecreased TNF-α production in whole blood after ex vivo LPS stimulation indicates suppression of the Toll-like receptor (TLR)4 pathway. This is associated with increased mortality in pediatric influenza critical illness. Whether antiviral immune signaling pathways are also suppressed in these patients is unclear.

objectivesWe sought to evaluate suppression of the TLR4 and the antiviral retinoic acid-inducible gene-I (RIG-I) pathways with clinical outcomes in children with severe influenza infection.

methodsIn this 24-center, prospective, observational cohort study of children with confirmed influenza infection, blood was collected within 72 hours of intensive care unit admission. Ex vivo whole blood stimulations were performed with matched controls using the viral ligand polyinosinic-polycytidylic acid-low-molecular-weight/LyoVec and LPS to evaluate IFN-α and TNF-α production capacities (RIG-I and TLR4 pathways, respectively).

resultsSuppression of either IFN-α or TNF-α production capacity was associated with longer duration of mechanical ventilation and hospitalization, and increased organ dysfunction. Children with suppression of both RIG-I and TLR4 pathways (n = 33 of 103 [32%]) were more likely to have prolonged (≥7 days) multiple-organ dysfunction syndrome (30.3% vs 8.6%; P = .004) or prolonged hypoxemic respiratory failure (39.4% vs 11.4%; P = .001) compared with those with single- or no pathway suppression.

conclusionsSuppression of both RIG-I and TLR4 signaling pathways, essential for respective antiviral and antibacterial responses, is common in previously immunocompetent children with influenza-related critical illness and is associated with bacterial coinfection and adverse outcomes. Prospective testing of both pathways may aid in risk-stratification and in immune monitoring.

Indexed as

AdolescentAntiviral AgentsChildChild, PreschoolCritical IllnessDEAD Box Protein 58FemaleHumansInfluenza, HumanInterferon-alphaMaleProspective StudiesReceptors, ImmunologicSignal TransductionToll-Like Receptor 4Tumor Necrosis Factor-alphaAntiviral AgentsDEAD Box Protein 58Interferon-alphaReceptors, ImmunologicRIGI protein, humanTLR4 protein, humanToll-Like Receptor 4Tumor Necrosis Factor-alphacritical careIFN-αinfluenzaLPSpediatricPolyinosinic:polycytidylic acidretinoic acid–inducible gene-IsuppressionTNF-αToll-like receptor 4

Identifiers

PMID32035159
PMCPMC7323584
OpenAlexW3004608596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.